@prefix ns1: <http://schema.org/> .

{
    <http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=276580> a ns1:MedicalCondition ;
        ns1:alternateName "Autosomal dominant hyperinsulinemic hypoglycemia due to Kir6.2 deficiency",
            "Dominant KATP hyperinsulinism due to Kir6.2 deficiency" ;
        ns1:code [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:276580" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "601820" ;
                ns1:codingSystem "OMIM" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "ORPHA:276580" ;
                ns1:codingSystem "ORPHAcode" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "E16.1" ;
                ns1:codingSystem "ICD-10" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "601820" ;
                ns1:codingSystem "OMIM" ],
            [ a ns1:MedicalCode ;
                ns1:codeValue "E16.1" ;
                ns1:codingSystem "ICD-10" ] ;
        ns1:description "A form of diazoxide-sensitive diffuse hyperinsulinism (DHI) characterized by hypoglycemic epiosodes that are usually mild, escaping detection during infancy, and usually a good clinical response to diazoxide, (but some are diazoxide resistant). Autosomal dominant hyperinsulinism due to Kir6.2 deficiency usually has a milder phenotype when compared to that resulting from recessive K+ (K-ATP) channel mutations (Recessive forms of diazoxide-resistant hyperinsulinism)." ;
        ns1:epidemiology "Prevalence : Unknown" ;
        ns1:identifier "276580" ;
        ns1:name [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Autosomal dominant hyperinsulinism due to Kir6.2 deficiency" ],
            [ a ns1:PronounceableText ;
                ns1:inLanguage "EN" ;
                ns1:textValue "Autosomal dominant hyperinsulinism due to Kir6.2 deficiency" ] .
}

